Analyst Ratings for GlaxoSmithKline (GSK) [Neutrals]

GSK Rating Summary

GSK Price Target Summary

* Over Last 12-Mos
  |   Expand Research on GSK
Overall Rating: NEUTRAL   Rating Trend: Down   Avg. $ Target: $45.50 (-0.1%) * Over Last 12-Mos
Rating Score: 1.8 / 10
Date Firm Type Rating
(Past)
PT
(Past)
Start $ End $ % Chg. Details
5/13/2015 UBS Downgrade Neutral
(Buy)
N/A
(N/A)
45.27 45.56 0.64% Details
1/24/2014 Berenberg Downgrade Hold
(Buy)
N/A
(N/A)
54.90 45.56 -17.01% Details
Like GSK Ratings? Also take a look at THRX, LGND, NVS, PFE

GSK Ratings News